What are the differences between Focalin (dexmethylphenidate) 20 mg and Concerta (extended‑release methylphenidate) 36 mg for treating ADHD, and how should I choose between them?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Focalin 20mg vs Concerta 36mg: Direct Comparison

Both Focalin (dexmethylphenidate) 20mg and Concerta (methylphenidate ER) 36mg are effective first-line stimulants for ADHD, but Focalin 20mg provides faster onset with stronger morning effect while Concerta 36mg delivers more sustained coverage through late afternoon and evening 1.

Key Pharmacological Differences

Active ingredient composition:

  • Focalin contains only the d-enantiomer (dexmethylphenidate), which is the pharmacologically active component
  • Concerta contains racemic methylphenidate (50% d-enantiomer, 50% inactive l-enantiomer)
  • This means Focalin 20mg delivers approximately equivalent therapeutic effect to Concerta 40mg in terms of active d-methylphenidate content 2, 3, 4

Duration and timing profiles:

  • Focalin 20mg: Bimodal release with peaks at ~1.5 hours and ~6.5 hours post-dose; total duration 8-10 hours 5, 2
  • Concerta 36mg: Osmotic-release system with gradual rise to peak at ~6-8 hours; total duration 10-12 hours 6

Clinical Performance Head-to-Head

The most relevant direct comparison study found that dexmethylphenidate ER 20mg demonstrated significantly superior efficacy versus methylphenidate ER 36mg at 2 hours post-dose (p<0.001) 2. However, this advantage reverses later in the day:

  • Morning/early day (0-6 hours): Focalin 20mg shows faster onset and greater symptom control 2, 7
  • Late afternoon/evening (10-12 hours): Concerta 36mg maintains better efficacy as Focalin's effect wanes 2

Both medications provided significant improvement over placebo at most timepoints throughout a 12-hour school day 2.

Choosing Between Them: Decision Algorithm

Select Focalin 20mg when:

  • Rapid symptom control in early morning is critical (school start, morning routines)
  • Coverage needed primarily during school hours (dismissal by 3-4pm)
  • Patient has difficulty with afternoon/evening rebound on other stimulants
  • Lower total methylphenidate exposure is desired (half the racemic dose)

Select Concerta 36mg when:

  • Extended coverage into late afternoon/evening is essential (homework, after-school activities, family time)
  • Smoother, more gradual onset is preferred
  • Patient needs consistent effect throughout a full 12-hour day
  • Once-daily dosing with minimal fluctuation is priority

Practical Considerations

Administration flexibility:

  • Both can be opened and sprinkled on applesauce if swallowing capsules/tablets is difficult 5, 8, 9
  • Focalin capsules contain beads; Concerta tablets use osmotic pump (cannot be cut/crushed) 6, 5

Common adverse effects are similar for both medications 1:

  • Decreased appetite
  • Sleep disturbances
  • Increased blood pressure/heart rate
  • Headaches

Monitor height, weight, pulse, and blood pressure regularly with either medication 10, 1.

Critical Caveat

The comparison of 20mg vs 36mg specifically is not equivalent dosing. Focalin 20mg delivers approximately 20mg of active d-methylphenidate, while Concerta 36mg delivers approximately 18mg of active d-methylphenidate (50% of 36mg). Therefore, Focalin 20mg is actually a slightly higher active dose than Concerta 36mg 3, 4. For truly equivalent dosing, compare Focalin 20mg to Concerta 40mg.

Titration principle: Both medications should be titrated to achieve maximum benefit with tolerable side effects, not simply compared at arbitrary doses 10, 1. The goal is individualized dose optimization based on symptom response and adverse effect profile throughout the day.

References

Research

Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2014

Research

Update on methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2021

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.